Sanofi eyes approval of COVID-19 vaccine by first half of 2021
Tuesday, 23 June 2020 ()
French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year.